The observed inhibitory effects of prion curing suggested that BTN3 downregulates protein trafficking and prion aggregation from BTN2-mediated URE3, which may prove crucial during the onset of mitochondrial complex 1 deficiency and Batten disease in humans. Here, BTNL9 is linked to hyperinsulinemic hypoglycemia, familial, 4.